ARS Pharmaceuticals, Inc.
Asset & Liabilities Breakdown
Asset Breakdown FY2025
Total Assets: $327.7M
Liabilities Breakdown FY2025
Total Liabilities: $213.4M
Asset Breakdown
Total Assets: $327.7M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $41.3M | 12.6% |
| Accounts Receivable | $25.3M | 7.7% |
| Inventory | $31.4M | 9.6% |
| Property, Plant & Equipment | $2.5M | 0.8% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $14.5M | 4.4% |
| Other Assets | $212.6M | 64.9% |
Liabilities Breakdown
Total Liabilities: $213.4M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $5.7M | 2.7% |
| Long-Term Debt | $96.4M | 45.2% |
| Other Liabilities | $111.3M | 52.2% |